Dow Jones

38,834.86

0.15%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

CYTR

CytRx (QB) (CYTR)

CytRx Corp (QB)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CYTR

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/06/2023	05:21	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CYTR	CytRx Corp (QB)
15/05/2023	05:29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CYTR	CytRx Corp (QB)
20/03/2023	05:08	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CYTR	CytRx Corp (QB)
14/02/2023	12:04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CYTR	CytRx Corp (QB)
28/07/2022	18:03	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CYTR	CytRx Corp (QB)
28/07/2022	15:06	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (d/a)	USOTC:CYTR	CytRx Corp (QB)
16/06/2022	15:16	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CYTR	CytRx Corp (QB)
16/06/2022	05:08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CYTR	CytRx Corp (QB)
03/06/2022	15:11	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:CYTR	CytRx Corp (QB)
19/05/2022	16:04	Edgar (US Regulatory)	Securities Registration (section 12(g)) (8-a12g)	USOTC:CYTR	CytRx Corp (QB)
28/03/2022	05:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:CYTR	CytRx Corp (QB)
25/03/2022	15:20	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:CYTR	CytRx Corp (QB)
15/02/2022	05:30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:CYTR	CytRx Corp (QB)
12/01/2022	09:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CYTR	CytRx Corp (QB)
04/08/2021	15:31	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:CYTR	CytRx Corp (QB)
29/07/2021	05:08	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:CYTR	CytRx Corp (QB)
13/07/2021	05:01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:CYTR	CytRx Corp (QB)
18/06/2021	11:07	Dow Jones News	Orphazyme, CytRx Shares Slide as FDA Rejects Arimoclomol	USOTC:CYTR	CytRx Corp (QB)
22/04/2021	05:16	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:CYTR	CytRx Corp (QB)
17/11/2020	05:11	Edgar (US Regulatory)	Amended Securities Registration (section 12(g)) (8-a12g/a)	USOTC:CYTR	CytRx Corp (QB)
23/10/2020	06:43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:CYTR	CytRx Corp (QB)
25/08/2020	09:12	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	USOTC:CYTR	CytRx Corp (QB)
13/08/2020	08:30	Edgar (US Regulatory)	Proxy Statement - Non-management (definitive) (defn14a)	USOTC:CYTR	CytRx Corp (QB)
10/08/2020	07:56	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prrn14a)	USOTC:CYTR	CytRx Corp (QB)
10/08/2020	05:05	Edgar (US Regulatory)	Proxy Statment - Contested Solicitations (definitive) (defc14a)	USOTC:CYTR	CytRx Corp (QB)
20/07/2020	08:27	Edgar (US Regulatory)	Proxy Statement - Contested Solicitations (preliminary) (prec14a)	USOTC:CYTR	CytRx Corp (QB)
27/05/2020	05:06	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:CYTR	CytRx Corp (QB)